에서 이용할 수 있어요!
자세히 알아보기
Biofrontera
BFRIW
BFRIW
상장폐지됨
BFRIW 종목은 2026년 10월 30일에 상장 폐지됐어요.
소개: Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.
직원 수: 94
뉴스
긍정적
중립
부정적
투자 심리
3개월
긍정적
0%
중립
100%
부정적
0%
가격 차트는 Lightweight Charts™ 라이브러리로 구현했어요